Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT
  Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunity

Power, A., Wang, J., Falls, T., Paterson, J., Parato, K., Lichty, B., et al. (2007). Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunity. Molecular Therapy, 15(1), 123-130. doi:10.1038/sj.mt.6300039.

Item is

Basisdaten

einblenden: ausblenden:
Genre: Zeitschriftenartikel

Externe Referenzen

einblenden:
ausblenden:
Beschreibung:
-
OA-Status:

Urheber

einblenden:
ausblenden:
 Urheber:
Power, AT1, Autor           
Wang , J, Autor
Falls, TJ, Autor
Paterson, JM, Autor
Parato, KA, Autor
Lichty, BD, Autor
Stojdl, DF, Autor
Forsyth, PA, Autor
Atkins, H, Autor
Bell, JC, Autor
Affiliations:
1External Organizations, ou_persistent22              

Inhalt

einblenden:
ausblenden:
Schlagwörter: -
 Zusammenfassung: Oncolytic viruses capable of tumor-selective replication and cytolysis have shown early promise as cancer therapeutics. However, the host immune system remains a significant obstacle to effective systemic administration of virus in a clinical setting. Here, we demonstrate the severe negative impact of the adaptive immune response on the systemic delivery of oncolytic vesicular stomatitis virus (VSV) in an immune-competent murine tumor model, an effect mediated primarily by the neutralization of injected virions by circulating antibodies. We show that this obstacle can be overcome by administering virus within carrier cells that conceal viral antigen during delivery. Infected cells were delivered to tumor beds and released virus to infect malignant cells while sparing normal tissues. Repeated administration of VSV in carrier cells to animals bearing metastatic tumors greatly improved therapeutic efficacy when compared with naked virion injection. Whole-body molecular imaging revealed that carrier cells derived from solid tumors accumulate primarily in the lungs following intravenous injection, whereas leukemic carriers disseminate extensively throughout the body. Furthermore, xenogeneic cells were equally effective at delivering virus as syngeneic cells. These findings emphasize the importance of establishing cell-based delivery platforms in order to maximize the efficacy of oncolytic therapeutics.

Details

einblenden:
ausblenden:
Sprache(n):
 Datum: 2007-01
 Publikationsstatus: Erschienen
 Seiten: -
 Ort, Verlag, Ausgabe: -
 Inhaltsverzeichnis: -
 Art der Begutachtung: -
 Identifikatoren: DOI: 10.1038/sj.mt.6300039
BibTex Citekey: PowerWFPPLSFAB2007
 Art des Abschluß: -

Veranstaltung

einblenden:

Entscheidung

einblenden:

Projektinformation

einblenden:

Quelle 1

einblenden:
ausblenden:
Titel: Molecular Therapy
Genre der Quelle: Zeitschrift
 Urheber:
Affiliations:
Ort, Verlag, Ausgabe: San Diego, CA : No longer published by Elsevier
Seiten: - Band / Heft: 15 (1) Artikelnummer: - Start- / Endseite: 123 - 130 Identifikator: ISSN: 1525-0016
CoNE: https://pure.mpg.de/cone/journals/resource/961066780010